Your session is about to expire
← Back to Search
Diagnostic Test
Cheek Swab vs Nasal/Throat Swab for COVID-19 Detection
N/A
Waitlist Available
Led By Stephen Freedman, MD
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 month recruitment timeframe
Awards & highlights
Study Summary
This trial will compare how well a swab from inside the cheek detects the coronavirus in kids, to the standard nose and throat swab.
Who is the study for?
This trial is for children under 18 who show up at certain emergency departments and are willing to get the standard COVID-19 test. They or their guardians must consent to participate and be able to communicate in English or French.Check my eligibility
What is being tested?
The study is testing a new way of checking for COVID-19 using buccal (cheek) swabs with a device called ID NOW, comparing it with the regular nose/throat swab tests at pediatric centers across Canada.See study design
What are the potential side effects?
There may not be significant side effects from the buccal swab itself, but some discomfort or gagging might occur during sample collection.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 month recruitment timeframe
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 month recruitment timeframe
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Buccal Swab Clinical Sensitivity
Secondary outcome measures
Accuracy of Testing Approach
Feasibility and Acceptability of Buccal Swab Collection
Trial Design
1Treatment groups
Experimental Treatment
Group I: COVID-19 Swab CollectionExperimental Treatment2 Interventions
All participants will receive standard of care COVID-19 testing in addition to buccal swab COVID-19 testing
Find a Location
Who is running the clinical trial?
University of CalgaryLead Sponsor
791 Previous Clinical Trials
865,852 Total Patients Enrolled
12 Trials studying COVID-19
16,183 Patients Enrolled for COVID-19
Health CanadaOTHER_GOV
31 Previous Clinical Trials
25,525 Total Patients Enrolled
2 Trials studying COVID-19
12,569 Patients Enrolled for COVID-19
Stephen Freedman, MDPrincipal InvestigatorUniversity of Calgary
9 Previous Clinical Trials
15,263 Total Patients Enrolled
2 Trials studying COVID-19
10,982 Patients Enrolled for COVID-19
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: COVID-19 Swab Collection
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any open slots available for new participants of this clinical investigation?
"According to clinicaltrials.gov, this trial is no longer recruiting participants as of October 20th 2022. Initially posted on November 10th 2021, this study has ceased recruitment at present; however, there are 1,056 other studies actively seeking patients right now."
Answered by AI
In what number of medical facilities is this experiment being conducted?
"This clinical trial is active at 14 sites, ranging from Kingston to London and Halifax. It would be most prudent for potential participants to select the closest site in order to minimize their travel needs."
Answered by AI
Share this study with friends
Copy Link
Messenger